Nephrotoxicity and Medicinal Plants
Nephrotoxicity and Medicinal Plants is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 7.3k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the health effects associated with aristolochic acid, a compound found in certain Chinese herbs, and its link to nephropathy, urothelial carcinoma, and acute interstitial nephritis. It explores the renal toxicity, mutation signatures, DNA adduct formation, and the potential carcinogenicity of aristolochic acid in herbal remedies.
- Aristolochic Acid
- Nephropathy
- Urothelial Carcinoma
- Chinese Herb
- Acute Interstitial Nephritis
- Renal Toxicity
- Mutation Signature
- Environmental Carcinogen
- DNA Adducts
- Herbal Remedies
- Research works
- 7.3k fractional, since 1950
- In the world top 10%
- 740 per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +24% the tick is no change
- Largest producer
China
39% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Nephrotoxicity and Medicinal Plants research?
By volume, China and the United States publish the most (386 and 209 works in 2022-now).
By volume, 2022-now
- 1
China
386 works
- 2
United States
209 works
- 3
India
118 works
- 4
Japan
82 works
- 5
South Korea
42 works
- 6
Germany
34 works
- 7
France
31 works
- 8
Türkiye
29 works
- 9
Spain
28 works
- 10
United Kingdom
27 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Nephrotoxicity and Medicinal Plants research?
By volume in 2022-now, Shanghai University of Traditional Chinese Medicine publishes the most Nephrotoxicity and Medicinal Plants research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Yale University.
By volume, 2022-now
- 1
Shanghai University of Traditional Chinese MedicineChina
13 works
- 2
Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina
12 works
- 3
Yale UniversityUnited States
11 works
- 4
Beijing University of Chinese MedicineChina
8 works
- 5
Johns Hopkins UniversityUnited States
8 works
- 6
Harvard UniversityUnited States
8 works
- 7
Mayo ClinicUnited States
7 works
- 8
Peking UniversityChina
6 works
- 9
Chinese Academy of SciencesChina
6 works
- 10
Nanjing University of Chinese MedicineChina
6 works
Who are the leading researchers in Nephrotoxicity and Medicinal Plants?
The most-cited researchers publishing on Nephrotoxicity and Medicinal Plants include Bert Vogelstein, Jun Wang and Giuseppe Remuzzi.
- 1
Bert Vogelstein
United States
373k citations
- 2
Jun Wang
China
340k citations
- 3
Giuseppe Remuzzi
Italy
328k citations
- 4
Amirhossein Sahebkar
Iran
258k citations
- 5
Kenneth W. Kinzler
United States
253k citations
- 6
Juan Jesús Carrero
Sweden
222k citations
- 7
Alberto Arduan Ortiz
Spain
219k citations
- 8
Michael R. Stratton
United Kingdom
203k citations
- 9
Michael Phillips
Australia
199k citations
- 10
Rinaldo Bellomo
Australia
182k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Nephrotoxicity and Medicinal Plants research done?
The largest centres of Nephrotoxicity and Medicinal Plants research in 2022-now are Beijing (China), Shanghai (China), Tokyo (Japan) and Guangzhou (China).
Where is the best place to study Nephrotoxicity and Medicinal Plants?
Among universities, judged by research, Shanghai University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College and Yale University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Shanghai University of Traditional Chinese MedicineChina |
81.6 | 20.6% | 37.6× | 13 | +123.7% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina |
77.6 | 22.1% | 9.2× | 12 | +32.0% |
| 3 | Yale UniversityUnited States |
20.0 | 4.4% | 8.3× | 11 | +484.2% |
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Nephrotoxicity and Medicinal Plants, country by countryIs Nephrotoxicity and Medicinal Plants research growing?
Output in 2022-2025 was 24% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Nephrotoxicity and Medicinal Plants.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Nephrotoxicity and Medicinal Plants as a percentage of every work published that year, 0.0062% in 2024.
Fractional works of Nephrotoxicity and Medicinal Plants over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Nephrotoxicity and Medicinal Plants. Posts are plain text and can be reported.